Correlates of exercise capacity in pediatric patients on chronic hemodialysis. 2013

Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
Pediatric Nephrology and Dialysis Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. fabiopaglialonga@alice.it

OBJECTIVE Pediatric patients on chronic hemodialysis (HD) are at high risk of inactivity and poor physical fitness. The aim of this study was to assess the main correlates of exercise capacity in a cohort of children and young adults on chronic HD. METHODS Twelve patients on chronic HD (median age 15.6 years; range 9.1-24.2) underwent a 6-minute walking test (WT), spirometry, a 1-minute chair stand test, and the measurement of lower extremity strength. Demographic data, anthropometry (dry weight, height, body mass index, and skinfold thickness, all expressed as standard deviation scores [SDS]), biochemistry (serum albumin, hemoglobin, creatinine, C-reactive protein, bicarbonate), bioimpedance analysis, HD adequacy indices (spKt/V and eKt/V), left ventricular mass index, and medications were also recorded. RESULTS There was a significant correlation among the distance covered during the WT (median 552 m, range 186-670), forced vital capacity (87.8% of predicted, range 49.7-136), forced expiratory volume in 1 second (86.7%, range 54.7-126.7), and peak expiratory flow (75.5%, 49.7-105.1). All of these indices positively correlated with the weight SDS (r 0.69-0.85), pre-HD serum creatinine (0.57-0.77), and serum albumin (0.60-0.77) and negatively correlated with weekly erythropoietin dose per kilogram of body weight (from -0.64 to -0.83), with P values ranging from <.05 to <.0005. Lower extremity strength (median 11.5 kg, range 3-15) positively correlated with the number of stands at the chair stand test (median 33, range 18-47; r 0.73, P < .05) and serum albumin (r 0.83, P < .01). Distance at the WT, forced vital capacity, lower extremity strength, and the number of stands at the chair stand test all negatively correlated with C-reactive protein levels (r from -0.81 to -0.67, P < .05). CONCLUSIONS Our findings show that protein-energy wasting and chronic inflammation are strongly correlated with the exercise capacity of children and young adults on chronic HD.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
June 2010, Arquivos brasileiros de cardiologia,
Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
January 1980, Israel journal of medical sciences,
Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
September 1984, The International journal of artificial organs,
Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
January 2005, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation,
Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
February 2002, Transplantation proceedings,
Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
December 1995, Artificial organs,
Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
October 1979, Nihon Jinzo Gakkai shi,
Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
April 1994, Advances in renal replacement therapy,
Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
January 2008, Journal of nephrology,
Fabio Paglialonga, and Amalia Lopopolo, and Rosalia Viviana Scarfia, and Maria Albina Galli, and Silvia Consolo, and Anna Brivio, and Maria Rosa Grassi, and Simona Salera, and Alberto Edefonti
June 1992, Kidney international,
Copied contents to your clipboard!